the aid library

Dreher, A.; A. Fuchs; B. Parks et al. AidData at William & Mary (2017) CC

This paper introduces a new dataset of official financing—including foreign aid and other forms of concessional and non-concessional state financing—from China to 138 countries between 2000 and 2014. We use these data to investigate whether and ... more

Tracking Chinese Development Finance: An Application of AidData’s TUFF 2.0 Methodology

Custer, S.; A. Dreher; T.-B. Elston et al. AidData at William & Mary (2021) CC

China and other so-called “emerging” donors and creditors are fundamentally changing the international development finance landscape; however, many of these actors do not participate in existing global reporting systems, such as the OECD’s Creditor Reporting System (CRS) and the International ... more

Download (175)

View PDF (170)

AidData's Tracking Underreported Financial Flows (TUFF) Methodology, Version 1.3.

Strange, A.; M. Cheng; B. Russell et al. AidData at William & Mary (2017) CC

This codebook outlines the set of TUFF procedures that have been developed, tested, refined, and implemented by AidData staff and affiliated faculty at the College of William & Mary. We initially employed these methods to achieve a specific objectiv... more

External Link

Immunological Interactions of Tuberculosis with Drugs and Substance Use: A Systematic Review and Update

N. G. Kiobi, S. N. Nebere, J. K. Karanja (2016) CC

Journal of Pulmonary & Respiratory Medicine 6: 326. doi:10.4172/2161-105X.1000326

Government policy interventions to reduce human antimicrobial use: A systematic review and evidence map

Van Katwyk, S. R.; Grimshaw, J. M.; et al (2019) C2

BACKGROUND: Growing political attention to antimicrobial resistance (AMR) offers a rare opportunity for achieving meaningful action. Many governments have developed national AMR action plans, but most have not yet implemented policy interventions to... reduce antimicrobial overuse. A systematic evidence map can support governments in making evidence-informed decisions about implementing programs to reduce AMR, by identifying, describing, and assessing the full range of evaluated government policy options to reduce antimicrobial use in humans. METHODS AND FINDINGS: Seven databases were searched from inception to January 28, 2019, (MEDLINE, CINAHL, EMBASE, PAIS Index, Cochrane Central Register of Controlled Trials, Web of Science, and PubMed). We identified studies that (1) clearly described a government policy intervention aimed at reducing human antimicrobial use, and (2) applied a quantitative design to measure the impact. We found 69 unique evaluations of government policy interventions carried out across 4 of the 6 WHO regions. These evaluations included randomized controlled trials (n = 4), non-randomized controlled trials (n = 3), controlled before-and-after designs (n = 7), interrupted time series designs (n = 25), uncontrolled before-and-after designs (n = 18), descriptive designs (n = 10), and cohort designs (n = 2). From these we identified 17 unique policy options for governments to reduce the human use of antimicrobials. Many studies evaluated public awareness campaigns (n = 17) and antimicrobial guidelines (n = 13); however, others offered different policy options such as professional regulation, restricted reimbursement, pay for performance, and prescription requirements. Identifying these policies can inform the development of future policies and evaluations in different contexts and health systems. Limitations of our study include the possible omission of unpublished initiatives, and that policies not evaluated with respect to antimicrobial use have not been captured in this review. CONCLUSIONS: To our knowledge this is the first study to provide policy makers with synthesized evidence on specific government policy interventions addressing AMR. In the future, governments should ensure that AMR policy interventions are evaluated using rigorous study designs and that study results are published. more

External Link

Tuberculosis and HIV Co-Infection

A. Pawlowski, M. Jansson, M. Sköld, et al. PLOS Phatogens (2012) CC

PLoS Pathogens | www.plospathogens.org 1 February 2012 | Volume 8 | Issue 2 | e100246

Download (141)

View PDF (136)

AidData's Methodology for Tracking Underreported Financial Flows, Version 1.1.

Strange, A. M.; B. O’Donnell; D. Gamboa et al. AidData at William & Mary (2013) CC

AidData has developed a set of open source data collection methods to track project-level data on suppliers of official finance who do not participate in global reporting systems. This codebook outlines the version 1.1 set of TUFF procedures that ha... more

Download (116)

View PDF (125)

Does Private Aid Follow the Flag? An Empirical Analysis of Humanitarian Assistance. AidData Working Paper #78

Fuchs, A. and Öhler, H. AidData at William & Mary (2019) CC

Little is known about foreign aid provided by private donors. This paper contributes to closing this research gap by comparing the allocation of private humanitarian aid to that of official humanitarian aid awarded to 140 recipient countries over the 2000-2016 period. We construct ... new database that offers information on the country in which the headquarters of private donors are located to test whether private donors follow the aid allocation pattern of their home country. Our empirical results confirm that private aid “follows the flag.” This finding is robust against the inclusion of various fixed effects, estimating instrumental variables models, and disaggregating private aid into corporate aid and NGO aid. Donor country-specific estimations reveal that private aid from China, Sweden, the United Kingdom, and the United States “follow the flag.” more

External Link

Chinese development assistance and household welfare in sub-Saharan Africa

Bruno Martorano, Laura Metzger, Marco Sanfilippo European University Institute (2019) C1

We combine data on Chinese development projects with data from Demographic and Health Surveys to study the impact of Chinese aid on household welfare in sub-Saharan Africa. We use a novel methodology to test the effect of Chinese aid on three import... more

External Link

SARS-CoV-2 Steckbrief zur Coronavirus-Krankheit-2019 (COVID-19)

Robert-Koch-Institut RKI (2020) C1

Stand 2.10.2020

Download (159)

View PDF (197)

Посттравматичний стресовий розлад як новий виклик сучасній україні

О. Л. Корольчук (2016) C1

Важкі умови життєдіяльності громадян, обтяжені веденням антитерористичної операції на Сході країни, призводять сьогодні до зростання кількості стресових та, нав�... more

Download (115)

View PDF (122)

Regional variation in the allocation of development assistance for health

Hanlon et al. Pubmed (2014) CC

The Global Burden of Disease (GBD) 2010 Study has published disability-adjusted life year (DALY) data at both regional and country levels from 1990 to 2010. Concurrently, the Institute for Health Metrics and Evaluation (IHME) has published estimates of development assistance for health (DAH) at th... more

Download (155)

View PDF (209)

Medikamentöse Therapie bei COVID-19 mit Bewertung durch die Fachgruppe COVRIIN am Robert Koch-Institut

Robert-Koch-Institut RKI (2021) C1

Änderung gegenüber der Version vom 26.1.2021: Aktualisierung der Informationen über monoklonale Antikörper und Rekonvaleszentenplasma